Related Experiment Video
Updated: Jul 4, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
Acquired resistance to Fas/CD95 ligation in U937 cells is associated with multiple molecular mechanisms
Jeanette Blomberg1, Kristina Ruuth, Daniel Santos
1Department of Molecular Biology, Umeå University, S-90187 Umeå, Sweden.
Background:
Acquired resistance to apoptosis is a critical event in tumour development and in insensitivity toward therapy. To investigate resistance mechanisms to Fas/CD95/Apo-1-induced apoptosis, a Fas ligand-resistant variant of the U937 cell line was generated.
Results:
Selection for Fas resistance resulted in a partial cross-resistance to TRAIL and TNF-alpha. Activation of caspase-8 was found to be impaired and the expression of Fas was reduced. However, FADD expression and ligand-induced aggregation of Fas was intact. Inhibition of various signalling pathways with pharmacological inhibitors revealed that resistance to death receptor-mediated apoptosis was dependent on altered tyrosine phosphatase/kinase activities and de novo protein synthesis. Moreover, FLIP, an anti-apoptotic protein, was expressed to a higher extent in the resistant cells.
Conclusion:
We provide evidence that acquired resistance to Fas-induced apoptosis in U937 cells involves a discrete set of molecular mechanisms which also render the cells cross-resistant to other death ligands.
Insights
Acquired resistance to apoptosis in U937 cells involves impaired caspase-8 activation and reduced Fas expression. These changes confer cross-resistance to other death ligands, impacting cancer therapy.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Immunology
Background:
- Acquired resistance to apoptosis is crucial in tumor development and therapy resistance.
- Investigating resistance to Fas/CD95/Apo-1-induced apoptosis is vital for understanding treatment failure.
Purpose of the Study:
- To generate a Fas ligand-resistant U937 cell line variant.
- To elucidate the molecular mechanisms underlying acquired resistance to Fas-induced apoptosis.
Main Methods:
- Generation of a Fas ligand-resistant U937 cell line.
- Analysis of caspase-8 activation, Fas expression, and FADD expression.
- Assessment of ligand-induced Fas aggregation.
- Pharmacological inhibition of signaling pathways.
- Evaluation of FLIP protein expression.
Main Results:
- Fas resistance led to partial cross-resistance to TRAIL and TNF-alpha.
- Impaired caspase-8 activation and reduced Fas expression were observed.
- FADD expression and Fas aggregation remained intact.
- Resistance correlated with altered tyrosine phosphatase/kinase activities and de novo protein synthesis.
- Elevated expression of the anti-apoptotic protein FLIP was noted in resistant cells.
Conclusions:
- Acquired resistance to Fas-induced apoptosis in U937 cells involves specific molecular mechanisms.
- These mechanisms confer cross-resistance to other death ligands, impacting therapeutic strategies.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Treatment Resistant Cancers
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Intracellular Signaling Affects Focal Adhesions
Some...

